Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · IEX Real-Time Price · USD

36.26

-0.76 (-2.05%)

At close: Apr 25, 2024, 4:00 PM

36.38

+0.12 (0.33%)

After-hours: Apr 25, 2024, 5:41 PM EDT

Celldex Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Revenue	6.88	2.36	4.65	7.42	3.57	9.54	12.74	6.79	5.48	3.59	Upgrade
Revenue Growth (YoY)	192.02%	-49.32%	-37.30%	107.61%	-62.54%	-25.15%	87.78%	23.83%	52.82%	-12.77%	Upgrade
Gross Profit	6.88	2.36	4.65	7.42	3.57	9.54	12.74	6.79	5.48	3.59	Upgrade
Selling, General & Admin	30.91	27.2	20.49	14.46	15.43	19.27	25	35.98	33.84	20.62	Upgrade
Research & Development	118.01	82.26	53.31	42.53	42.67	66.45	96.17	102.73	100.17	104.38	Upgrade
Other Operating Expenses	12.5	15	3.5	18	1.8	109.88	13.9	1	1.01	1.01	Upgrade
Operating Expenses	161.43	124.45	77.3	74.99	59.9	195.6	135.07	139.7	135.02	126.02	Upgrade
Operating Income	-154.54	-122.1	-72.65	-67.57	-56.33	-186.06	-122.33	-132.92	-129.54	-122.43	Upgrade
Other Expense / Income	-13.11	-9.77	-1.91	-6.63	-5.45	-34.11	-5.01	-4.39	-2.34	-4.35	Upgrade
Pretax Income	-141.43	-112.33	-70.74	-60.95	-50.88	-151.95	-117.31	-128.53	-127.2	-118.08	Upgrade
Income Tax	0	0	-0.23	-1.17	0	-0.77	-24.28	0	0	0	Upgrade
Net Income	-141.43	-112.33	-70.51	-59.78	-50.88	-151.18	-93.03	-128.53	-127.2	-118.08	Upgrade
Shares Outstanding (Basic)	48	47	43	30	15	10	9	7	6	6	Upgrade
Shares Outstanding (Diluted)	48	47	43	30	15	10	9	7	6	6	Upgrade
Shares Change	3.33%	9.37%	44.64%	104.32%	38.93%	21.84%	26.61%	4.62%	8.56%	12.06%	Upgrade
EPS (Basic)	-2.92	-2.40	-1.64	-2.02	-3.51	-14.48	-10.86	-18.99	-19.65	-19.80	Upgrade
EPS (Diluted)	-2.92	-2.40	-1.64	-2.02	-3.51	-14.48	-10.86	-18.99	-19.65	-19.80	Upgrade
Free Cash Flow	-109.11	-105.49	-62.13	-41.9	-47.13	-75.71	-101.72	-115.79	-103.76	-103.47	Upgrade
Free Cash Flow Per Share	-2.25	-2.25	-1.45	-1.41	-3.25	-7.25	-11.87	-17.11	-16.04	-17.36	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-2245.27%	-5180.14%	-1561.99%	-910.92%	-1576.41%	-1950.69%	-959.95%	-1958.68%	-2363.89%	-3414.11%	Upgrade
Profit Margin	-2054.76%	-4765.59%	-1516.04%	-805.88%	-1423.96%	-1585.07%	-730.06%	-1894.05%	-2321.11%	-3292.81%	Upgrade
Free Cash Flow Margin	-1585.20%	-4475.65%	-1335.86%	-564.86%	-1318.95%	-793.73%	-798.23%	-1706.26%	-1893.49%	-2885.28%	Upgrade
EBITDA	-138.42	-109.43	-67.67	-57.02	-46.02	-148.15	-112	-124.44	-123.19	-114.68	Upgrade
EBITDA Margin	-2011.06%	-4642.72%	-1454.96%	-768.64%	-1287.99%	-1553.24%	-878.94%	-1833.75%	-2247.92%	-3197.96%	Upgrade
Depreciation & Amortization	3.01	2.9	3.07	3.93	4.86	3.8	5.31	4.09	4.01	3.4	Upgrade
EBIT	-141.43	-112.33	-70.74	-60.95	-50.88	-151.95	-117.31	-128.53	-127.2	-118.08	Upgrade
EBIT Margin	-2054.76%	-4765.59%	-1520.92%	-821.61%	-1423.96%	-1593.09%	-920.61%	-1894.05%	-2321.11%	-3292.81%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).